SURENA MATIN to Drug Resistance, Neoplasm
This is a "connection" page, showing publications SURENA MATIN has written about Drug Resistance, Neoplasm.
Connection Strength
0.062
-
Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma. Cancer Immunol Res. 2015 Sep; 3(9):1017-29.
Score: 0.049
-
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma. Oncogene. 2016 05; 35(21):2687-97.
Score: 0.013